LU82673A1 - Homogenes fibroblasten-interferon und dessen herstellung - Google Patents

Homogenes fibroblasten-interferon und dessen herstellung Download PDF

Info

Publication number
LU82673A1
LU82673A1 LU82673A LU82673A LU82673A1 LU 82673 A1 LU82673 A1 LU 82673A1 LU 82673 A LU82673 A LU 82673A LU 82673 A LU82673 A LU 82673A LU 82673 A1 LU82673 A1 LU 82673A1
Authority
LU
Luxembourg
Prior art keywords
interferon
column
human fibroblast
hplc
eluted
Prior art date
Application number
LU82673A
Other languages
German (de)
English (en)
Inventor
Heinz J Friesen
S Pestka
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of LU82673A1 publication Critical patent/LU82673A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
LU82673A 1979-07-31 1980-07-30 Homogenes fibroblasten-interferon und dessen herstellung LU82673A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US6237179A 1979-07-31 1979-07-31
US6237179 1979-07-31
US13063580A 1980-03-14 1980-03-14
US13063580 1980-03-14

Publications (1)

Publication Number Publication Date
LU82673A1 true LU82673A1 (fr) 1982-02-17

Family

ID=26742182

Family Applications (1)

Application Number Title Priority Date Filing Date
LU82673A LU82673A1 (fr) 1979-07-31 1980-07-30 Homogenes fibroblasten-interferon und dessen herstellung

Country Status (33)

Country Link
US (1) US5015730A (fr)
JP (1) JPH02138226A (fr)
AR (1) AR229931A1 (fr)
AT (1) AT372387B (fr)
AU (1) AU536274B2 (fr)
CA (1) CA1146468A (fr)
CH (1) CH648331A5 (fr)
DE (1) DE3028919A1 (fr)
DK (1) DK159825C (fr)
DO (1) DOP1980002948A (fr)
ES (1) ES8200560A1 (fr)
FI (1) FI70721C (fr)
FR (1) FR2462167B1 (fr)
GB (1) GB2055384B (fr)
HK (1) HK40384A (fr)
HU (1) HU185382B (fr)
IE (1) IE50075B1 (fr)
IL (1) IL60697A (fr)
IT (1) IT1132269B (fr)
KE (1) KE3364A (fr)
LU (1) LU82673A1 (fr)
MC (1) MC1337A1 (fr)
MY (1) MY8500274A (fr)
NL (1) NL8004361A (fr)
NO (1) NO151158C (fr)
NZ (1) NZ194495A (fr)
PH (2) PH17738A (fr)
PT (1) PT71625B (fr)
RO (1) RO81474B (fr)
SE (1) SE466290B (fr)
YU (1) YU193480A (fr)
ZA (1) ZA803943B (fr)
ZW (1) ZW17980A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI88175C (fi) 1980-04-03 1993-04-13 Biogen Inc Rekombinant-dna-molekyler och foerfaranden foer framstaellning av polypeptider liknande humant -interferon
IL63916A0 (en) * 1980-09-25 1981-12-31 Genentech Inc Microbial production of human fibroblast interferon
ZA83768B (en) * 1982-03-01 1983-10-26 Hoffmann La Roche Homogeneous human immune interferon and process therefor
US4966843A (en) * 1982-11-01 1990-10-30 Cetus Corporation Expression of interferon genes in Chinese hamster ovary cells
US4569790A (en) * 1984-03-28 1986-02-11 Cetus Corporation Process for recovering microbially produced interleukin-2 and purified recombinant interleukin-2 compositions
US4530787A (en) * 1984-03-28 1985-07-23 Cetus Corporation Controlled oxidation of microbially produced cysteine-containing proteins
US4894330A (en) * 1986-12-23 1990-01-16 Cetus Corporation Purification of recombinant beta-interferon incorporating RP-HPLC
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
US20050002902A1 (en) * 1995-12-28 2005-01-06 Liming Yu Hybrid with interferon-alpha and an immunoglobulin Fc for treatment of tumors and viral infections
US5723125A (en) * 1995-12-28 1998-03-03 Tanox Biosystems, Inc. Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide
US20030026779A1 (en) * 1999-10-15 2003-02-06 Liming Yu Treatment of tumors and viral infections with a hybrid conjugate of interferon and an immunoglobulin Fc
RS57549B1 (sr) 2005-08-26 2018-10-31 Ares Trading Sa Proces za pripremu glikoziliranog interferona beta
CA2625978A1 (fr) 2005-12-09 2007-06-14 Ares Trading S.A. Procede de purification de la fsh ou d'un mutant de la fsh
CA2702448A1 (fr) * 2007-10-22 2009-04-30 Merck Serono S.A. Procede de purification de proteines de fusion avec fc
DE102009032179A1 (de) 2009-07-07 2011-01-13 Biogenerix Ag Verfahren zur Reinigung von Interferon beta

Also Published As

Publication number Publication date
HK40384A (en) 1984-05-18
HU185382B (en) 1985-01-28
PH17738A (en) 1984-11-23
FI70721C (fi) 1986-10-06
MY8500274A (en) 1985-12-31
IT8023801A0 (it) 1980-07-30
IE50075B1 (en) 1986-02-05
IE801589L (en) 1981-01-31
CA1146468A (fr) 1983-05-17
NO151158B (no) 1984-11-12
SE466290B (sv) 1992-01-27
NZ194495A (en) 1984-07-31
PH18479A (en) 1985-07-18
AT372387B (de) 1983-09-26
FR2462167A1 (fr) 1981-02-13
RO81474A (fr) 1983-04-29
AU6091480A (en) 1981-02-05
YU193480A (en) 1984-04-30
DK159825B (da) 1990-12-10
DE3028919C2 (fr) 1988-02-18
SE8005498L (sv) 1981-02-01
ATA395080A (de) 1983-02-15
ZW17980A1 (en) 1981-03-18
DE3028919A1 (de) 1981-02-19
AR229931A1 (es) 1984-01-31
IT1132269B (it) 1986-07-02
IL60697A0 (en) 1980-09-16
MC1337A1 (fr) 1981-04-21
GB2055384B (en) 1983-08-10
IL60697A (en) 1984-04-30
GB2055384A (en) 1981-03-04
NO151158C (no) 1985-02-20
DK328880A (da) 1981-02-01
NL8004361A (nl) 1981-02-03
PT71625B (en) 1981-12-17
DOP1980002948A (es) 1989-04-20
FI802400A (fi) 1981-02-01
JPH02138226A (ja) 1990-05-28
CH648331A5 (de) 1985-03-15
ZA803943B (en) 1981-06-24
ES493849A0 (es) 1981-11-16
FR2462167B1 (fr) 1985-07-05
RO81474B (ro) 1983-04-30
US5015730A (en) 1991-05-14
PT71625A (en) 1980-08-01
FI70721B (fi) 1986-06-26
KE3364A (en) 1984-02-03
DK159825C (da) 1991-04-29
AU536274B2 (en) 1984-05-03
ES8200560A1 (es) 1981-11-16
NO802297L (no) 1981-02-02

Similar Documents

Publication Publication Date Title
DE2947134C2 (fr)
DE3485945T2 (de) Gereinigter transformierender wachstum-beta-faktor aus humanen plaketten und plazenten stammend.
Gospodarowicz et al. Fibroblast growth factor in the human placenta
Gospodarowicz et al. Isolation of pituitary fibroblast growth factor by fast protein liquid chromatography (FPLC): partial chemical and biological characterization
DE3922089A1 (de) Neue proteine und ihre herstellung
LU82673A1 (fr) Homogenes fibroblasten-interferon und dessen herstellung
Böhlen et al. Human brain fibroblast growth factor: Isolation and partial chemical characterization
DE3650088T2 (de) Inhibin und dessen reinigung.
EP0101063B1 (fr) Polypeptide ayant une activité sur le système immunitaire, procédé pour son isolement et sa purification, son application et composition le contenant
DE68927458T2 (de) Endothelialzellen-Wachstumsfaktor
DE69231169T2 (de) Verfahren zur Herstellung von Interleukin-6
HK Weise et al. Snake Venom Toxins. The Purification of Toxins V II 1 and V II 2, Two Cytotoxin Homologues from Banded Egyptian Cobra (Naja haje annulifera) Venom, and the Complete Amino Acid Sequence of Toxin V II 1
Lobb et al. Comparison of human and bovine brain derived heparin-binding growth factors
DE3421731A1 (de) Humaner-tumor-nekrose-faktor
DE3687246T2 (de) Antitumor-polypeptid und dessen methode zur herstellung.
KR840001516B1 (ko) 인체 섬유아세포 인터페론의 제조방법
DE69525450T2 (de) Beta taipoxin als ein zell-wachstumsfaktor und methode zu seiner darstellung
DE3782276T2 (de) Interleukin-2 induziertes antineoplastisches peptid.
US5545720A (en) Protein PHBP-70
DE3426049A1 (de) Humaner-tumor-nekrose-faktor
DE2954574C2 (de) Pharmazeutische Präparate enthaltend Human-Leukozyten-Interferon
EP0133308B1 (fr) Agent pour le contrôle de l'appétit et son procédé de préparation
DE2023447A1 (de) Insulinderivate und Verfahren zu ihrer Herstellung
JPH0832727B2 (ja) 純化されたヒト血小板由来血管内皮細胞増殖因子及び純化する方法
EP0308424A1 (fr) Nouvelle proteine designee neuroleukine

Legal Events

Date Code Title Description
DT Application date
TA Annual fee